Literature DB >> 9058300

Colonic cancer in a patient with primary sclerosing cholangitis and long-standing ulcerative colitis.

M Seo1, M Okada, S Osamura, S Hara, T Umeno, K Maeshiro, Y Yamada, K Yuh.   

Abstract

A 27-year-old woman with a 9-year history of ulcerative colitis involving the entire colon was admitted to our hospital in August 1992 because of bloody stools and left lower abdominal pain. She had been treated with sulfasalazine since 1983 and the colitis had been clinically quiescent or mild for 7 years. She had also been diagnosed as having primary sclerosing cholangitis (PSC) 4 years prior to this admission, based on the clinical, laboratory, and cholangiographic findings. A barium enema and colonoscopy showed an irregular mass obstructing the bowel lumen in the distal portion of the descending colon. Biopsy specimens taken from the mass revealed moderately differentiated adenocarcinoma, and a subtotal colectomy was performed. Histologic examination of the mass lesion showed moderately differentiated adenocarcinoma invading the pericolic adipose tissue. She is currently alive 3 years after surgery. PSC has recently been reported as a risk factor for colonic neoplasia in patients with long-standing ulcerative colitis. In Japan, however, colorectal cancer associated with PSC and ulcerative colitis has rarely been reported. The present case suggests that the risk of colonic cancer is higher in patients with ulcerative colitis and PSC than in patients with ulcerative colitis alone.

Entities:  

Mesh:

Year:  1997        PMID: 9058300     DOI: 10.1007/bf01213301

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  25 in total

1.  Course and prognosis of ulcerative colitis: Part IV Carcinoma of the colon.

Authors: 
Journal:  Gut       Date:  1964-02       Impact factor: 23.059

2.  Primary sclerosing cholangitis: a long-term follow-up study.

Authors:  E Aadland; E Schrumpf; O Fausa; K Elgjo; A Heilo; T Aakhus; E Gjone
Journal:  Scand J Gastroenterol       Date:  1987-08       Impact factor: 2.423

3.  Outcome of primary sclerosing cholangitis. Analysis of long-term observation of 38 patients.

Authors:  E Lebovics; M Palmer; J Woo; F Schaffner
Journal:  Arch Intern Med       Date:  1987-04

4.  Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis.

Authors:  J R Cangemi; R H Wiesner; S J Beaver; J Ludwig; R L MacCarty; R R Dozois; A R Zinsmeister; N F LaRusso
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

5.  Controlled clinical trials: the controls are the key.

Authors:  D J Ahnen
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

Review 6.  Primary sclerosing cholangitis.

Authors:  Y Ueno; N F LaRusso
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

7.  Sclerosing cholangitis in ulcerative colitis. A follow-up study.

Authors:  E Schrumpf; O Fausa; F Kolmannskog; K Elgjo; S Ritland; E Gjone
Journal:  Scand J Gastroenterol       Date:  1982-01       Impact factor: 2.423

8.  Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy.

Authors:  M O Blackstone; R H Riddell; B H Rogers; B Levin
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

Review 9.  Bile duct carcinoma in patients with ulcerative colitis. Relationship to sclerosing cholangitis: report of six cases and review of the literature.

Authors:  S H Mir-Madjlessi; R G Farmer; M V Sivak
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

10.  Current concepts. Primary sclerosing cholangitis.

Authors:  N F LaRusso; R H Wiesner; J Ludwig; R L MacCarty
Journal:  N Engl J Med       Date:  1984-04-05       Impact factor: 91.245

View more
  2 in total

1.  Rapid progression of primary sclerosing cholangitis complicated with ulcerative colitis.

Authors:  Piotr Pardak; Ewa Walczak; Rafał S Filip
Journal:  Case Rep Gastrointest Med       Date:  2015-01-28

2.  Rectal-sparing type of ulcerative colitis predicts lack of response to pharmacotherapies.

Authors:  Yuki Horio; Motoi Uchino; Toshihiro Bando; Teruhiro Chohno; Hirofumi Sasaki; Akihiro Hirata; Yoshio Takesue; Hiroki Ikeuchi
Journal:  BMC Surg       Date:  2017-05-19       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.